Higher numbers of T-bet+ intratumoral lymphoid cells correlate with better survival in gastric cancer

Cancer Immunology, Immunotherapy

Volumn 62, Issue 3, 2013, Pages 553-561

  Chen, Lu Jun ^a   Zheng, Xiao ^a   Shen, Yue Ping ^b   Zhu, Yi Bei ^c   Li, Qing ^a   Chen, Junjun ^a   Xia, Rui ^c   Zhou, Shu Ming ^d   Wu, Chang Ping ^a   Zhang, Xue Guang ^c   Lu, Bin Feng ^e   Jiang, Jing Ting ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^d Yixing Tumor Hospital   (China)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Gastric cancer; Prognosis; T bet; Tumor infiltrating lymphocyte

Indexed keywords

CD56 ANTIGEN; TRANSCRIPTION FACTOR T BET; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR TBX21; T-BOX TRANSCRIPTION FACTOR TBX21;

ADULT; ADVANCED CANCER; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; GASTRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID CELL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH POLYP; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; CYTOLOGY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; STOMACH; STOMACH TUMOR;

CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; PROGNOSIS; STOMACH; STOMACH NEOPLASMS; T-BOX DOMAIN PROTEINS;

MLCS; MLOWN;

EID: 84877132569     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1358-6     Document Type: Article

References (21)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277-300
2. Gajewski TF, Meng Y, Harlin H (2006) Immune suppression in the tumor microenvironment. J Immunother 29(3):233-240 (Pubitemid 44297291)
3. Finn OJ (2008) Cancer immunology. N Engl J Med 358(25):2704-2715 (Pubitemid 351860863)
4. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pages F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795):1960-1964 (Pubitemid 44498003)
5. Glimcher LH (2007) Trawling for treasure: tales of T-bet. Nat Immunol 8(5):448-450 (Pubitemid 46605908)
6. Werneck MB, Lugo-Villarino G, Hwang ES, Cantor H, Glimcher LH (2008) T-bet plays a key role in NK-mediated control of melanoma metastatic disease. J Immunol 180(12):8004-8010
7. Garrett WS, Punit S, Gallini CA, Michaud M, Zhang D, Sigrist KS, Lord GM, Glickman JN, Glimcher LH (2009) Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell 16(3):208-219
8. Lipscomb MW, Chen L, Taylor JL, Goldbach C, Watkins SC, Kalinski P, Butterfield LH, Wesa AK, Storkus WJ (2009) Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1 T cells in vitro. J Immunol 183(11):7250-7258
9. Qu Y, Chen L, Pardee AD, Taylor JL, Wesa AK, Storkus WJ (2010) Intralesional delivery of dendritic cells engineered to express T-bet promotes protective type 1 immunity and the normalization of the tumor microenvironment. J Immunol 185(5):2895-2902
10. Zhu Y, Ju S, Chen E, Dai S, Li C, Morel P, Liu L, Zhang X, Lu B (2010) T-bet and Eomesodermin are required for T cell-mediated antitumor immune responses. J Immunol 185(6):3174-3183
11. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353(25):2654-2666 (Pubitemid 41817714)
12. LH S, C W (2002) TNM Classification of Malignant Tumours (6th edited). UICC (International Union Against Cancer): 65-68
13. Chen LJ, Sun J, Wu HY, Zhou SM, Tan Y, Tan M, Shan BE, Lu BF, Zhang XG (2011) B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol Immunother 60(7):1047-1055
14. Sun J, Chen L, Zhang G, Jiang J, Zhu M, Tan Y, Wang H, Lu B, Zhang X (2010) Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunol Immunother 59(8):1163-1171
15. Peng SL, Townsend MJ, Hecht JL, White IA, Glimcher LH (2004) T-bet regulates metastasis rate in a murine model of primary prostate cancer. Cancer Res 64(2):452-455 (Pubitemid 38120881)
16. Stoicov C, Fan X, Liu JH, Bowen G, Whary M, Kurt-Jones E, Houghton J (2009) T-bet knockout prevents Helicobacter felis-induced gastric cancer. J Immunol 183(1):642-649
17. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100(6):655-669
18. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, Livingston DM, Kung AL, Cereb N, Yao TP, Yang SY, Reiner SL (2001) Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292(5523):1907-1910 (Pubitemid 32538365)
19. Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331(6024):1565-1570
20. Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M, Naka T, Ojima T, Ueda K, Hayata K, Nakamura Y, Yamaue H (2011) Tumor-infiltrating CD4 + Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol Rep 25(5):1271-1277
21. De Monte L, Reni M, Tassi E, Clavenna D, Papa I, Recalde H, Braga M, Di Carlo V, Doglioni C, Protti MP (2011) Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med 208(3):469-478